EC
ANIP icon

Elequin Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Elequin Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
26
+11
+73% +$882 ﹤0.01% 539
2026
Q1 		$1.15K Sell
15
-36
-71% -$2.81K ﹤0.01% 532
2025
Q4 		$4.03K Buy
+51
New +$4.42K ﹤0.01% 318
2025
Q3 		– Sell
-30
Closed -$1.96K – 157
2025
Q2 		$1.96K Buy
+30
New +$1.95K ﹤0.01% 324
2025
Q1 		– Sell
-2
Closed -$111 – 338
2024
Q4 		$111 Sell
2
-229
-99% -$13.1K ﹤0.01% 486
2024
Q3 		$13.8K Buy
+231
New +$14.1K ﹤0.01% 208

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Elequin Capital's ANIP Position: Q2 2026 in Review

Elequin Capital increased its ANI Pharmaceuticals (ANIP) stake by 73% in Q2 2026, buying an estimated $882 and bringing the position to 26 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Elequin Capital first reported a position in ANIP in Q3 2024 and has held it in 6 quarters since. The position peaked at $13.8K in Q3 2024. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Elequin Capital held 26 shares of ANI Pharmaceuticals worth $2.15K as of Q2 2026.
  • Elequin Capital bought 11 ANI Pharmaceuticals shares in Q2 2026, an estimated $882.
  • ANI Pharmaceuticals made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #539 holding.
  • Elequin Capital first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Elequin Capital's ANI Pharmaceuticals position peaked at $13.8K in Q3 2024.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.